Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Royal Philips Acquires Spectranetics
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with its acquisition by a wholly owned subsidiary of Royal Philips,…
Bristol-Myers Squibb Company Debt Tender Offer
Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875% notes due 2036, 6.125% notes due 2038 and 6.875% debentures due…
Marble II $500 Million High-Yield Notes Offering
Davis Polk advised the joint global coordinators, joint lead managers and joint bookrunners on a Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.30…
Back to top